文献速递心血管MR

高血压且有心脏磁共振临床指征患者的二尖瓣环平面收缩期位移预后意义:一项多中心研究

Prognostic Implications of Mitral Annular Plane Systolic Excursion in Patients with Hypertension and a Clinical Indication for Cardiac Magnetic Resonance Imaging: A Multicenter Study.
PubMed 文献 · JACC Cardiovasc Imaging · 2018-11-05

该多中心研究纳入1735例高血压且有CMR临床指征的患者,测量四腔心 cine 视图的侧壁MAPSE。中位随访5.1年期间235例死亡,侧壁MAPSE每降低1 mm与死亡风险独立相关(HR 1.402),且加入模型后C统计量从0.735提升至0.815。

要点

  • 侧壁MAPSE每降低1 mm,死亡风险独立升高(HR 1.402,p<0.001)。
  • 侧壁MAPSE低于中位数10 mm者死亡风险显著更高(log-rank p<0.0001)。
  • 校正整体纵向应变后,侧壁MAPSE仍与死亡独立相关(HR 1.192)。

核心结论

  • CMR来源的侧壁MAPSE是高血压且有CMR临床指征患者死亡的强独立预测因子,其预后价值超越常见临床和CMR危险因素。

研究设计与样本

  • 多中心连续纳入4家美国医学中心的高血压且有CMR临床指征患者共1735例,在四腔心 cine 视图测量侧壁MAPSE,主要终点为全因死亡,采用Cox比例风险回归和嵌套模型评估增量预后价值。

关键影像表现/征象

  • 侧壁MAPSE在四腔心 cine 视图上测量,代表长轴二尖瓣环运动。
  • 侧壁MAPSE低于中位数10 mm的患者死亡风险显著更高(log-rank p<0.0001)。

诊断标准与关键数值

  • 侧壁MAPSE每降低1 mm,全因死亡风险HR为1.402(p<0.001)。
  • 加入侧壁MAPSE后C统计量从0.735提升至0.815(p<0.0001)。
  • 连续净重分类改善为0.739(95%CI 0.601–0.902)。
  • 校正特征追踪整体纵向应变后,侧壁MAPSE每降低1 mm的HR为1.192(p<0.001)。
  • 射血分数保留亚组HR为1.339(p<0.001),无心肌梗死病史亚组HR为1.390(p<0.001)。

临床应用与阅片要点

  • 在高血压患者CMR阅片时,可于四腔心 cine 视图测量侧壁MAPSE以辅助风险分层。
  • 侧壁MAPSE的预后信息独立于临床危险因素、常见CMR指标及整体纵向应变。
  • 作者认为这些发现可能提示CMR来源的侧壁MAPSE有助于识别死亡风险最高的高血压患者。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: This study sought to evaluate the prognostic value of cardiac magnetic resonance (CMR)-derived mitral annular plane systolic excursion (MAPSE) in a large multicenter population of patients with hypertension.

BACKGROUND: In patients with hypertension, cardiac abnormalities are powerful predictors of adverse outcomes. Long-axis mitral annular movement plays a fundamental role in cardiac mechanics and is an early marker for a number of pathological processes. Given the adverse consequences of cardiac involvement in hypertension, the authors hypothesized that lateral MAPSE may provide incremental prognostic information in these patients.

METHODS: Consecutive patients with hypertension and a clinical indication for CMR at 4 U.S. medical centers were included in this study (n = 1,735). Lateral MAPSE was measured in the 4-chamber cine view. The primary endpoint was all-cause death. Cox proportional hazards regression modeling was used to examine the association between lateral MAPSE and death. The incremental prognostic value of lateral MAPSE was assessed in nested models.

RESULTS: Over a median follow-up period of 5.1 years, 235 patients died. By Kaplan-Meier analysis, risk of death was significantly higher in patients with a lateral MAPSE < median (10 mm) (log-rank; p < 0.0001). Lateral MAPSE was associated with risk of death after adjustment for clinical and imaging risk factors (hazard ratio [HR]: 1.402-per-millimeter decrease; p < 0.001). Addition of lateral MAPSE in this model resulted in significant improvement in the C-statistic (0.735 to 0.815; p < 0.0001). Continuous net reclassification improvement was 0.739 (95% confidence interval: 0.601 to 0.902). Lateral MAPSE remained significantly associated with death even after adjustment for feature tracking global longitudinal strain (HR: 1.192-per-millimeter decrease; p < 0.001). Lateral MAPSE was independently associated with death among the subgroups of patients with preserved ejection fraction (HR = 1.339; p < 0.001) and in those without history of myocardial infarction (HR: 1.390; p < 0.001).

CONCLUSIONS: CMR-derived lateral MAPSE is a powerful, independent predictor of mortality in patients with hypertension and a clinical indication for CMR, incremental to common clinical and CMR risk factors. These findings may suggest a role for CMR-derived lateral MAPSE in identifying hypertensive patients at highest risk of death.

来源:JACC Cardiovasc Imaging,查看原文。版权归原作者所有。

引用

  1. Romano S, Judd RM, Kim RJ, et al. Prognostic Implications of Mitral Annular Plane Systolic Excursion in Patients with Hypertension and a Clinical Indication for Cardiac Magnetic Resonance Imaging: A Multicenter Study. JACC Cardiovasc Imaging. 2018. PMID: 30409557. doi:10.1016/j.jcmg.2018.10.003

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。